Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like The positive impact of ULEZ on children’s health and environment September 5, 2024 Employee burnout leads to significant financial losses for companies February 27, 2025 Researchers receive CAD 45 million to study new psychosis treatments November 6, 2024